Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 48,257 | 13,608 | 17,331 | 26,293 | 19,643 |
| Cost of Goods | 1,368 | 1 | N/A | 0 | N/A |
| Gross Profit | 46,889 | 13,607 | 17,331 | 26,293 | 19,643 |
| Operating Expenses | 86,701 | 59,379 | 48,048 | 60,181 | 69,230 |
| Operating Income | -39,444 | -45,771 | -30,717 | -33,888 | -49,587 |
| Interest Expense | 5,200 | 4,998 | 4,778 | 4,666 | 3,774 |
| Other Income | 1,625 | 5,580 | 5,387 | -527 | -3,587 |
| Pre-tax Income | -43,019 | -45,189 | -30,108 | -39,081 | -56,948 |
| Net Income Continuous | -43,019 | -45,189 | -30,108 | -39,081 | -56,948 |
| Net Income | $-43,019 | $-45,189 | $-30,108 | $-39,081 | $-56,948 |
| EPS Basic Total Ops | -0.59 | -0.68 | -0.55 | -0.79 | -1.26 |
| EPS Basic Continuous Ops | -0.59 | -0.68 | -0.55 | -0.79 | -1.26 |
| EPS Diluted Total Ops | -0.59 | -0.68 | -0.55 | -0.79 | -1.26 |
| EPS Diluted Continuous Ops | -0.59 | -0.68 | -0.55 | -0.79 | -1.26 |
| EBITDA(a) | $-38,255 | $-45,005 | $-29,974 | $-32,821 | $-48,345 |